0001387131-18-006726.txt : 20181210 0001387131-18-006726.hdr.sgml : 20181210 20181210200202 ACCESSION NUMBER: 0001387131-18-006726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181206 FILED AS OF DATE: 20181210 DATE AS OF CHANGE: 20181210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cartwright Daniel A CENTRAL INDEX KEY: 0001532231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-00100 FILM NUMBER: 181227583 MAIL ADDRESS: STREET 1: 951 BROKEN SOUND PARKWAY NW STREET 2: SUITE 320 CITY: BOCA RATON STATE: FL ZIP: 33487 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TherapeuticsMD, Inc. CENTRAL INDEX KEY: 0000025743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870233535 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487 BUSINESS PHONE: 561-961-1911 MAIL ADDRESS: STREET 1: 6800 BROKEN SOUND PARKWAY NW STREET 2: THIRD FLOOR CITY: BOCA RATON STATE: FL ZIP: 33487 FORMER COMPANY: FORMER CONFORMED NAME: AMHN, Inc. DATE OF NAME CHANGE: 20090930 FORMER COMPANY: FORMER CONFORMED NAME: CROFF ENTERPRISES INC DATE OF NAME CHANGE: 19970915 FORMER COMPANY: FORMER CONFORMED NAME: CROFF OIL CO DATE OF NAME CHANGE: 19920703 4 1 cartwright-form4_120618.xml OWNERSHIP DOCUMENT X0306 4 2018-12-06 0 0000025743 TherapeuticsMD, Inc. TXMD 0001532231 Cartwright Daniel A 6800 BROKEN SOUND PKWY NW, THIRD FLOOR BOCA RATON FL 33487 0 1 0 0 CFO Common Stock 2018-12-06 4 M 0 40000 0.38 A 40000 D Common Stock 2018-12-06 4 S 0 40000 4.57 D 40000 D Non-Qualified Stock Option (right to buy) 0.38 2018-12-06 4 M 0 40000 0 D 2012-10-21 2021-10-21 Common Stock 40000 180000 D The sales were made pursuant to the Reporting Person's 10b5-1 trading plan with respect to shares of Common Stock underlying options to purchase Common Stock. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.44 to $4.68, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Daniel A. Cartwright 2018-12-10